« Return to News | Awards & Advancement

Avila names Hirsch CFO

Tuesday, July 12, 2011 10:14 AM

Avila Therapeutics, a biotechnology company developing targeted covalent drugs, has named Andrew Hirsch its first chief financial officer.

"As we continue to drive drug development programs arising from the Avilomic platform into the clinic, Andrew's nearly 20 years in corporate finance and strategic management will be a tremendous asset to Avila. His breadth of experience provides us with key insights into successfully creating value as we advance our drug candidates and grow as an organization," said Katrine Bosley, CEO of Avila.

Hirsch joins Avila from Biogen Idec, where he spent the past 10 years in a number of roles, most recently as vice president of corporate strategy and M&A. Previously, he led business development for a software startup and spent several years in management consulting at Stern Stewart and The Parthenon Group.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.